Cancers evade immunotherapy by ‘discarding the evidence’ of tumor-specific mutations – EurekAlert (press release)
|
Cancers evade immunotherapy by 'discarding the evidence' of tumor-specific mutations
EurekAlert (press release) Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic … |
